Related references
Note: Only part of the references are listed.Api m 6 and Api m 10 as Major Allergens in Patients With Honeybee Venom Allergy
A. Vega-Castro et al.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2022)
Maintenance venom immunotherapy administered at 12-week intervals in patients with high basal tryptase
Stefano Pucci et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2022)
Integration of in vitro allergy test results and ratio analysis for the diagnosis and treatment of allergic patients (INTEGRA)
Mariona Pascal et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2021)
The prevalence of Api m 10 sensitization and the modification of immunotherapy in bee venom allergy
Aleksandra Gorska et al.
POSTEPY DERMATOLOGII I ALERGOLOGII (2021)
Hymenoptera Venom Allergy: Re-Sting reactions
A. M. Mesquita et al.
EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Comparison of the Safety Profiles of 3 Different Hymenoptera Venom Immunotherapy Protocols: A Retrospective 2-Center Study of 143 Patients
Isabella Maria Pospischil et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2020)
Hymenoptera Venom Allergy: Management of Children and Adults in Clinical Practice
M. B. Bilo et al.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2019)
EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy
G. J. Sturm et al.
ALLERGY (2018)
Next generation immunotherapy for tree pollen allergies
Yan Su et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Diagnostics in hymenoptera venom allergy: current concepts and developments with special focus on molecular allergy diagnostics
Thilo Jakob et al.
ALLERGO JOURNAL (2017)
Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis
S. Dhami et al.
ALLERGY (2017)
Varicella vaccine without human serum albumin versus licensed varicella vaccine in children during the second year of life: a randomized, double-blind, non-inferiority trial
Roman Prymula et al.
BMC PEDIATRICS (2016)
Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy
Marcel Frick et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Risk Associated with Bee Venom Therapy: A Systematic Review and Meta-Analysis
Jeong Hwan Park et al.
PLOS ONE (2015)
Venom Immunotherapy: an Updated Review
Dario Antolin-Amerigo et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2014)
Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines
M. T. Krishna et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2011)
Low prevalence of IgE to cross-reactive carbohydrate determinants in beekeepers
Francisco-Javier Carballada et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: The importance of baseline serum tryptase
Franziska Rueff et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Venom immunotherapy reduces large local reactions to insect stings
David B. K. Golden et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy
Gabriele Di Lorenzo et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Work-related anaphylaxis to wasp sting
Antonio Perez-Pimiento et al.
OCCUPATIONAL MEDICINE-OXFORD (2007)
Prevention and treatment of hymenoptera venom allergy:: guidelines for clinical practice
F Bonifazi et al.
ALLERGY (2005)
Rush venom immunotherapy in patients experiencing recurrent systemic reactions to conventional venom immunotherapy
A Goldberg et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2003)
Addressing parents' concerns: Do vaccines contain harmful preservatives, adjuvants, additives, or residuals?
PA Offit et al.
PEDIATRICS (2003)
Side-effects of insect venom immunotherapy:: results from an EAACI multicenter study
H Mosbech et al.
ALLERGY (2000)